EAM
ISEE

EverPoint Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

EverPoint Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-250,000
Closed -$11.5M – 558
2016
Q3 		$11.5M Buy
+250,000
New +$14.1M 0.21% 125

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EverPoint Asset Management's ISEE Position: Q4 2016 in Review

EverPoint Asset Management opened a new position in IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016: 250,000 shares worth $1.21M. The stake represents 0.02% of the portfolio and ranks #363 among its holdings.

137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • EverPoint Asset Management held 250,000 shares of IVERIC bio, Inc. Common Stock worth $1.21M as of Q4 2016.
  • IVERIC bio, Inc. Common Stock was a new EverPoint Asset Management position in Q4 2016.
  • IVERIC bio, Inc. Common Stock made up 0.02% of EverPoint Asset Management's portfolio in Q4 2016, its #363 holding.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.